ESTIMATE algorithm indicated that, compared with the low-risk group, high-risk patients had higher StromalScore and ESTIMATEScore, while ImmuneScore did not reach statistical significance ( Fig. 8 A–C).
← all excerpts
A machine learning-based prognostic signature utilizing MSC proteomics for predicting bladder cancer prognosis and treatment response.
1
—
—